Chief Accounting Officer
Precision Biosciences Inc (DTIL)Equibles does not estimate personal net worth.
Get an email with a short summary when Precision Biosciences Inc publishes a filing, an earnings call transcript or a press release.
Get DTIL alertsAlex Kelly is recorded as COO at Precision Biosciences Inc (DTIL) since August 1, 2026, Chief Accounting Officer at Precision Biosciences Inc (DTIL) since September 15, 2023 and CFO at Precision Biosciences Inc (DTIL). Precision Biosciences Inc reported in an 8-K filed July 27, 2026 that Alex Kelly was appointed Chief Operating Officer, effective August 1, 2026. Precision Biosciences Inc reported in an 8-K filed September 7, 2023 that Alex Kelly was appointed principal accounting officer, effective September 15, 2023. The proxy statement of Precision Biosciences Inc reports total compensation of $1,134,116 for Alex Kelly in fiscal 2025, including a base salary of $472,525. Disclosed compensation is on record for 5 fiscal years. Alex Kelly has spoken on 1 investor event across 1 company, most recently for Precision Biosciences Inc on April 14, 2026. Precision Biosciences Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Precision Biosciences Inc includes Matthew Kane (CEO), Naresh Tanna (CFO), Dario Scimeca (General Counsel) and 7 others.
“As part of these leadership changes, the Board appointed Alex Kelly, age 60, as Chief Operating Officer of the Company.”
“On September 6, 2023, the Company's Board of Directors designated Alex Kelly, the Company's Chief Financial Officer and principal financial officer, to also serve as the Company's principal accounting officer effective upon Mr. Barton's departure.”
“Good to be here, Gil, and thank you to the Needham team for inviting us to present at the conference. So, Cassie, if you can advance the next slide quickly, just as Gil introduced, I'm the CFO at Precision, and Cassie Gorsuch is our Chief Scientific Officer.”
2026-08-01–present
SEC 8-K
2023-09-15–present
2023-09-15–present
Biotechnology · Healthcare
CFO, COO, Chief Accounting Officer
2023-09-15–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Precision Biosciences Inc (DTIL) | Chief Financial Officer | $472,525 | $1,134,116 |
| 2024 | Precision Biosciences Inc (DTIL) | Chief Financial Officer | $461,000 | $1,893,387 |
| 2023 | Precision Biosciences Inc (DTIL) | Chief Financial Officer | $457,667 | $1,084,388 |
| 2022 | Precision Biosciences Inc (DTIL) | Chief Financial Officer | $437,500 | $2,378,839 |
| 2021 | Precision Biosciences Inc (DTIL) | Chief Financial Officer | $420,000 | $3,319,324 |
